MCP-4
N/A
Report date: 2023/02/18 23:49:12
Base Information
Drug NameMCP-4
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[3]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHuman Genome Sciences IncGlaxosmithkline Plc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesGlaxosmithkline PlcHuman Genome Sciences Inc
Active IndicationsN/A
Inactive Indications +[3]
Other Information
ATC CodeN/A
Related LinksN/A